Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Tarrytown, New York 10591


The purpose of this study is: 1. To assess and characterize the PK and PD of PRO 140 administered IV 2. To assess the antiviral activity of PRO 140 3. To assess the safety and tolerability of PRO 140


Inclusion Criteria: 1. Males & females, age ≥ 18 years (or minimum adult age as determined by local regulatory authorities) 2. Screening plasma HIV-1 RNA ≥ 5,000 copies/mL 3. CD4+ T-lymphocyte cell count ≥ 300 cells/mm3 and no documented count < or = 250 cells/mm3 4. Has not taken any anti-retroviral therapy (ART) w/in 12 wks of Early Screening Visit 5. Exclusive CCR5-tropic virus as determined by Trofile™ Assay at Early Screening Visit 6. Clinically normal or "not clinically significant (NCS)" resting electrocardiogram 7. Women of reproductive potential must have a negative serum pregnancy test at Late Screening Visit & a negative urine pregnancy test w/in 72 hrs prior to first dose of study medication, & be non-lactating. Male & female subjects must agree not to participate in a conception process from Early Screening Visit through Day 59. Exclusion Criteria: 1. CXCR4 tropic virus or dual/mixed tropic (R5X4) virus determined by the Trofile™ Assay. 2. Females who are pregnant, lactating or breastfeeding, or who plan to become pregnant during the study. 3. History of active hepatitis within the previous 24 wks 4. Prior use of any entry, attachment, CCR5 co-receptor or fusion inhibitor, experimental or approved.



Primary Contact:

Study Director
Stephen Morris, MD, PhD
Progenics Pharmaceuticals, Inc.

Backup Contact:


Location Contact:

Tarrytown, New York 10591
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: February 04, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.